Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Technology Update

5 Apr 2007 10:18

ViaLogy PLC05 April 2007 Date: 5 April 2007On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For Immediate Release ViaLogy plc Technology Update • ViaLogy offers aerospace industry a highly scaleable platform for integrating emerging wireless MEMS and RFID Devices • Will potentially accelerate adoption of lightweight composites for aerospace and semiconductor applications LONDON, April 5, 2007 -- ViaLogy plc (AIM: VIY): ViaLogy presented a network-centric interoperable sensor- signal- processing platform deployingembedded MEMS and RFID sensors at the CANEUS/NASA "Fly-By-Wireless" Workshopheld in conjunction with the 5th Annual RFID World Congress in Grapevine, TX. Lightweight composites are becoming increasingly important in aircraft,aerospace structures, transportation systems and underground oil and gaspipelines. To date, most of the work has focused on deploying and machiningcomposites for control surfaces, skin, structures and cryogenic tanks andvessels. While high stiffness, strength, superior fatigue tolerance to thermalvariations and stealthy radar cross section make composites very attractive,their adoption has been rather limited due to high cost, manufacturability,complex failure mechanisms and maintainability. Typically, design-to-reliabilitychallenges can be overcome with additional structure health monitoring circuitryand sensors. However, this is very difficult to achieve for composites withcurrent technology, without surface mounting hundreds of hardwired stress andstrain gauges and other sensors to detect incipient micro-fracture which canrapidly degenerate to total structure failure. Thus aerospace and reusablelaunch vehicle engineering has been limited in exploiting the promise ofcomposites due to weight and power overhead from additional sensors. ViaLogy's Pulsed Microwave Data Link (PMDLTM) platform combines synergisticadvances in MEMS sensors, power optimized active radio-frequency (RF) scanningfor embedded MEMS/RFID tag interrogation, internet protocol-enabled MEMSinteroperability for wireless interconnect switches, smart summarization andweak signal processing to extract diagnostic signatures. ViaLogy has a patentpending on this solution. PMDLTM addresses two challenges unique to embedded wireless MEMS/RFIDimplementations with inherent requirements for high scalability; namelycontinuous monitoring for degradation, recalibration and mortality of thedevices themselves and resulting uncertainty in signature quality, and abilityof proprietary weak signal processing to robustly extract failure-modes andsignatures in high clutter RF environments with complex propagation propertiesintrinsic to molecular constructs seen in composites. Dr. Sandeep Gulati, ViaLogy CTO and VP for Product Development, commented; "Weare focused on broad market applications where our network centric and sensoragnostic weak signal processing platform becomes an enabler. In addition, we seea convergence between our wireless MEMS and RFID solutions and an immediatevalue proposition in increasing RFID read accuracy for embedded tags in theaerospace industry." Dr. John Mai, Product Manager for RFID Platforms, recently joined ViaLogy tohead this effort. Previously, Dr. Mai was the Special Assistant to the GeneralDirector of the RFID Technology Center (RTC) within the Industrial TechnologyResearch Institute, Hsinchu, Taiwan. There, he was involved with all of theCenter's advanced projects ranging from all-printed RFID developments to next-generation, compact UHF RFID readers. He also initiated a polymer-MEMS device R&D program between the RTC and Stanford University. According to Dr. Mai, an aerospace engineer by training; "Localizing a crack ina epoxy composite cryogenic propellant tank using embedded MEMS sensors orcorrectly reading a metallic RFID tag embedded within a multilayer compositeprinted circuit board, buried deep in a loaded pallet present the same clutterrejection challenge. There is an economic penalty which can quickly propagateand escalate for missed detection in both cases." He added, "As the supply-chainindustry moves towards item level tagging, fast and accurate read capabilityenabled by PMDLTM, will become a market differentiator". Dr. Mai is leveraging his experience in business with the Asia-Pacific region toposition this ViaLogy solution into a market that it is believed could consume48% of the world's RFID tags by 2010. For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626 296 6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.